You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

List of Excipients in API nelfinavir mesylate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing nelfinavir mesylate

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
HJ Harkins Company Inc	VIRACEPT	nelfinavir mesylate	52959-289	CALCIUM SILICATE
HJ Harkins Company Inc	VIRACEPT	nelfinavir mesylate	52959-289	CROSPOVIDONE
HJ Harkins Company Inc	VIRACEPT	nelfinavir mesylate	52959-289	FD&C BLUE NO. 2
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for nelfinavir mesylate

Excipient focus: CALCIUM SILICATE

nelfinavir mesylate drug variants containing CALCIUM SILICATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
HJ Harkins Company Inc	nelfinavir mesylate	52959-289
State of Florida DOH Central Pharmacy	nelfinavir mesylate	53808-0809
AGOURON	nelfinavir mesylate	63010-010
>Company	>Ingredient	>NDC

nelfinavir mesylate drug variants not containing CALCIUM SILICATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

nelfinavir mesylate drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
HJ Harkins Company Inc	nelfinavir mesylate	52959-289
State of Florida DOH Central Pharmacy	nelfinavir mesylate	53808-0809
AGOURON	nelfinavir mesylate	63010-010
>Company	>Ingredient	>NDC

nelfinavir mesylate drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C BLUE NO. 2

nelfinavir mesylate drug variants containing FD&C BLUE NO. 2

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
HJ Harkins Company Inc	nelfinavir mesylate	52959-289
AGOURON	nelfinavir mesylate	63010-010
>Company	>Ingredient	>NDC

nelfinavir mesylate drug variants not containing FD&C BLUE NO. 2

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
State of Florida DOH Central Pharmacy	nelfinavir mesylate	53808-0809
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

nelfinavir mesylate drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
State of Florida DOH Central Pharmacy	nelfinavir mesylate	53808-0809
AGOURON	nelfinavir mesylate	63010-010
>Company	>Ingredient	>NDC

nelfinavir mesylate drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
HJ Harkins Company Inc	nelfinavir mesylate	52959-289
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

nelfinavir mesylate drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
HJ Harkins Company Inc	nelfinavir mesylate	52959-289
>Company	>Ingredient	>NDC

nelfinavir mesylate drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
State of Florida DOH Central Pharmacy	nelfinavir mesylate	53808-0809
AGOURON	nelfinavir mesylate	63010-010
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

nelfinavir mesylate drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
HJ Harkins Company Inc	nelfinavir mesylate	52959-289
State of Florida DOH Central Pharmacy	nelfinavir mesylate	53808-0809
AGOURON	nelfinavir mesylate	63010-010
>Company	>Ingredient	>NDC

nelfinavir mesylate drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

nelfinavir mesylate drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
State of Florida DOH Central Pharmacy	nelfinavir mesylate	53808-0809
>Company	>Ingredient	>NDC

nelfinavir mesylate drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
HJ Harkins Company Inc	nelfinavir mesylate	52959-289
AGOURON	nelfinavir mesylate	63010-010
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

nelfinavir mesylate drug variants containing TRIACETIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
HJ Harkins Company Inc	nelfinavir mesylate	52959-289
State of Florida DOH Central Pharmacy	nelfinavir mesylate	53808-0809
AGOURON	nelfinavir mesylate	63010-010
>Company	>Ingredient	>NDC

nelfinavir mesylate drug variants not containing TRIACETIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.